All Akkermansia articles
-
NewsGut microbiota disruption predicts severe steatosis in MASLD patients
A new study links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic liver disease (MASLD). In a 61-patient cohort, those with the inflammation-linked Bact2 enterotype developed severe steatosis at lower thresholds.
-
NewsThe hidden drivers of aging: microbial influence on genomic stability and telomere dynamics
A new review synthesizes current evidence on how microbial dysbiosis accelerates aging by disrupting genomic integrity and telomere dynamics, while also exploring therapeutic strategies to promote healthy longevity.
-
NewsCocktails of antibiotics, probiotics and prebiotics hold promise in treating a common form of irritable bowel syndrome
Personalised “cocktails” of antibiotics, probiotics and prebiotics hold great promise in the treatment of a common form of irritable bowel syndrome (IBS), a new study suggests.
-
NewsMicrobial signature of colorectal cancer-associated mutations identified in new study
Researchers have identified microbiota signatures associated with KRAS mutations in people diagnosed with colorectal cancer, suggesting that gut microbes may serve as a kind of non-invasive biomarker for identifying subtypes of CRC.
-
-
NewsStudy finds diverse differences in microbes in breast tumours from women of different races
The breast tumours of Asian, black and white women have very different cellular, microbial and genomic features that could potentially be used to personalize care or predict disease progression, according to new research by investigators at the Johns Hopkins Kimmel Cancer Center. Source: National Cancer Institute Potential ...